Sodium-glucose cotransporter-2 inhibitor for renal function preservation in patients with type 2 diabetes mellitus: A Korean Diabetes Association and Korean Society of Nephrology consensus statement

Diabetes is a leading cause of end-stage renal disease. Therefore, prevention of renal dysfunction is an important treatment goal in the management of diabetes. The data of landmark cardiovascular outcome trials of sodiumglucose cotransporter-2 (SGLT2) inhibitors showed profound reno-protective effe...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Tae Jung Oh, Ju-Young Moon, Kyu Yeon Hur, Seung Hyun Ko, Hyun Jung Kim, Taehee Kim, Dong Won Lee, Min Kyong Moon, The Committee of Clinical Practice Guideline, Korean Diabetes Association and Committee of the Cooperative Studies, Korean Society of Nephrology
Format: Artigo
Jezik:Inglês
Izdano: The Korean Society of Nephrology 2020-09-01
Serija:Kidney Research and Clinical Practice
Teme:
diabetes mellitus
type 2
glomerular filtration rate
renal function
sodium-glucose transporter-2 inhibitors
Online dostop:https://doi.org/10.23876/j.krcp.20.132
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki